Right On Brands, Inc. (RTON)
Oxford Ledge is still expanding full research coverage of RTON. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Right on Brands markets CBD and hemp-derived products through multiple sales channels and emphasizes formulation and quality to compete in the hemp consumer products market.
Source: 10-K (2023-03-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Entry into material agreement 2024-07-25
- 8-K Entry into material agreement 2024-07-16
- 8-K Entry into material agreement 2024-07-12
- 10-Q Quarterly financial report (unaudited) 2024-04-15
- 8-K Other material event 2024-03-01
Source: SEC EDGAR.
Annual results
5 years of annual figures for RTON, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2023 | $1.1M | $8,726 | $0.00 |
| 2022 | $997,100 | -$257,016 | — |
| 2021 | $77,960 | -$1.9M | — |
| 2020 | $328,580 | -$3.5M | — |
| 2019 | $255,821 | -$6.1M | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
- Open RTON in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.